Navigation Links
IVCC launches groundbreaking insecticide projects with Bayer and Syngenta
Date:9/11/2007

The Innovative Vector Control Consortium (IVCC) has embarked upon the next phase of its initial five year strategy with the launch of the first tranche of funded projects to develop new public health mosquito control products. The three projects, with partners Bayer CropScience and Syngenta, complement established IVCC projects developing improved mosquito control information systems.

The Syngenta project, in association with the London School of Hygiene and Tropical Medicine (LSHTM), will seek to develop a new long lasting Indoor Residual Spray (IRS) formulation to help control malaria and other diseases transmitted by mosquito vectors.

The first Bayer CropScience project, in partnership with the Medical Research Council, South Africa, the Liverpool School of Tropical Medicine (LSTM) and LSHTM, is also aimed at developing a long lasting IRS formulation for malaria and other vector borne diseases. The second Bayer project includes LSTM and the University of Liverpool as partners to modify current active insecticide ingredients to overcome pesticide resistance.

Commenting on the projects, IVCC Chief Executive Janet Hemingway said: The launch of these projects is the next stage in the development of IVCC as an organisation playing a key role in the development of new public health insecticides and better vector control information systems.

Several other IVCC-supported projects are already making good progress in the development of tools which will enable pesticides to be deployed more effectively and efficiently.

We are now looking at funding a further tranche of projects, including the development of entirely new active ingredients for pesticides that will greatly improve vector control in disease endemic countries.

Prof. Dr. Friedrich Berschauer, Chairman of the Board of Management of Bayer CropScience AG said: This partnership is a clear sign for us that our expertise and our long-term commitment to fight malaria by offering effective products in vector control has been acknowledged. We are very proud to work with the IVCC on finding a sustainable solution in the combat of one of the worlds most devastating diseases.

Kris Sirchio, Global Head of Professional Products at Syngenta said: We are delighted to be a lead partner with the IVCC and to have reached this important milestone. Syngenta is a world-leading innovator in insecticide technology and we are committed to delivering products that improve health and quality of life. Combining our capabilities with those of IVCC will help accelerate the development of new vector management programs which will benefit communities where the need is greatest.


'/>"/>

Contact: Alan Hughes
a.p.hughes@liv.ac.uk
Liverpol School of Tropical Medicine
Source:Eurekalert

Related medicine news :

1. Glaxo launches pills to help smokers quit in 7-12 weeks
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. Dr Reddy’s Laboratories launches Hyalosy
4. Serum Institute Launches New Tetanus-Diphtheria Vaccine
5. Scottish Health Minister Launches Organ Donor Plan
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
8. Pfizer Launches Viagra For Lung Disease In UK
9. PM Launches Healthcare Foundation For India
10. African Union Launches A Programme On Acceleration of HIV Prevention
11. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , ... March 28, 2017 , ... ... is pleased to be invited to the Siemens Healthineers annual customer education symposium, ... The event will take place from March 27 - 31, 2017 at the ...
(Date:3/28/2017)... ... 2017 , ... Medforce Technologies, Inc., a leading provider of ... joined the National Association for Home Care and Hospice (NAHC), the largest and ... Americans of all ages and the caregiver who provide them with in-home health ...
(Date:3/28/2017)... ... 28, 2017 , ... WHO: , Dr. Paul Thomas; Dr. Brian Hooker; Dr. ... and PhD scientists will speak to the press on behalf of over 200 doctors, ... independent vaccine safety commission. , WHERE: , Zenger Room, National Press Club, 529 ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... relocated its corporate headquarters to a new, more expansive office space in order ... 2016, Qualidigm purchased a distressed office building in Wethersfield, Conn. located at 936 ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Executives, Staff & ... money to for the Toys for Tots Literacy Campaign at their Semi-Annual Graduation and ... of $70 billion, the U.S. ranks at number 14 internationally in literacy. Statistically, a ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... "Chemotherapy Induced Neutropenia (CIN) – Market Insights, Epidemiology and Market Forecast-2023" ... of the Chemotherapy Induced Neutropenia for the seven major markets i.e., ... ( France , Germany , ... Japan , as well as rest of ... The Report covers the therapeutics market revenue, treatment practice ...
(Date:3/28/2017)... -- "US Cancer Generics Market Outlook 2022" report gives ... analysis related to the emergence and integration of ... US. The report analyzes various clinical and non-clinical ... drugs in recent years. The introduction of generics ... for various stake holders involved US cancer drug ...
(Date:3/28/2017)... TORONTO , March 28, 2017 /PRNewswire/ - ... service medical device development firm, announced today that it ... Toronto -based medical device industrial design and productization ... companies throughout North America with ... device talent spanning the design, engineering, regulatory, and manufacturing ...
Breaking Medicine Technology: